| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Advanced therapy medicinal products: Regulatory framework, hospital and pharmaceutical circuits in Europe and France
|
Mebarki, Miryam
|
|
|
77 |
2 |
p. 185-190
|
article
|
| 2 |
Dermatological adverse drug reactions of anticancer drugs: International data of pharmacovigilance: VigiBase®
|
Strumia, Mathilde
|
|
|
77 |
2 |
p. 219-227
|
article
|
| 3 |
Editorial board
|
|
|
|
77 |
2 |
p. i
|
article
|
| 4 |
From cardio-oncology to cardio-onco-pharmacology: Towards a multidisciplinary approach in the understanding and management of cardiotoxicity
|
Ederhy, Stéphane
|
|
|
77 |
2 |
p. 197-206
|
article
|
| 5 |
Hemato-oncopharmacology: Drugs and cancer
|
Kiladjian, Jean-Jacques
|
|
|
77 |
2 |
p. 149-150
|
article
|
| 6 |
Immunotherapies in acute leukemia
|
Boissel, Nicolas
|
|
|
77 |
2 |
p. 241-250
|
article
|
| 7 |
Of some innovations in clinical trial design in hematology and oncology
|
Lévy, Vincent
|
|
|
77 |
2 |
p. 191-195
|
article
|
| 8 |
Pharmacoepidemiology for oncology clinical practice: Foundations, state of the art and perspectives
|
de Germay, Sibylle
|
|
|
77 |
2 |
p. 229-240
|
article
|
| 9 |
Pharmacogenomics in solid cancers and hematologic malignancies: Improving personalized drug prescription
|
Maillard, Maud
|
|
|
77 |
2 |
p. 171-183
|
article
|
| 10 |
Pharmacokinetics and therapeutic drug monitoring of anticancer protein/kinase inhibitors
|
Bouchet, Stéphane
|
|
|
77 |
2 |
p. 157-170
|
article
|
| 11 |
Pharmacology and pharmacovigilance of protein kinase inhibitors
|
Khouri, Charles
|
|
|
77 |
2 |
p. 207-217
|
article
|
| 12 |
The challenge of targets and drug discovery using large-scale screening approaches in onco-hematology
|
Benajiba, Lina
|
|
|
77 |
2 |
p. 151-155
|
article
|
| 13 |
The “old” cytotoxic drugs, the basis of anti-cancer treatments
|
Manfredi, Sylvain
|
|
|
77 |
2 |
p. 251-255
|
article
|
Journal description